The Centers for Medicare & Medicaid Services (CMS) on Wednesday finalized its Skilled Nursing Facility Prospective Payment ...

Collaboration with Vilnius University Hospital Santaros Klinikos on HG-CT-1 Clinical Application and Research LONDON, UK / ...

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with ...

A phase 2 study of Agios Pharmaceuticals’ next-generation pyruvate kinase (PK) activator has failed to support continued ...

Keros Therapeutics, Inc. ("Keros") (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics ...

Nonrelapse mortality dropped to a single death across 94 transplants, which the authors linked to consistent prophylaxis and supportive care rather than to any new therapy.

Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T cell engagers in autoimmune ...

Imagine a patient leaving a skilled nursing facility on a Tuesday. She can stand with her walker, transfer to a chair with ...

New funding will further extend virtual urgent care, preventive health services and primary care navigation programs for low-income, uninsured and underinsured adults in New York City.The expanded ...

Skilled nursing facilities in 2027 will get a 2.4% payment increase based on the final rule released by the Centers for Medicare & Medicaid Services on Wednesday. The amount is based on a final SNF ...

The UAE's first ADC-accredited undergraduate dental program pairs international recognition with one of the region's largest ...

Cellares secures new funding, partnerships and FDA recognition as it prepares for commercial-scale cell therapy manufacturing ...